The Immune Response

to Cancer Diagnostics

 

In the media :

Tuesday 15 November 2016 - Journal for ImmunoTherapy of Cancer:   Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation    |     Saturday 12 November 2016 - American Pharmacy News:   HalioDx reports progress on clinical research services    |     Monday 07 November 2016 - Biotechgate Global Database:   HalioDx launches Immunoseek CR (CD8/PD-L1), a new assay toward precision immunotherapy    |     Thursday 03 November 2016 - PM360:   HalioDx is successfully implementing its range of service offering to pharmaceutical companies    |     Sunday 23 October 2016 - CCI Nice Côte d'Azur:   PASS FRENCH TECH PACA - Biotech, MedTech, Cleantech et Industrie    |     Wednesday 19 October 2016 - Pharmacy Choice:   10/18/16 - FDA Approves Genentech's Cancer Immunotherapy TECENTRIQ (Atezolizumab) for People with a Specific Type of Metastatic Lung Cancer    |     Tuesday 18 October 2016 - GoMet':   HalioDx lance Immunoscore, un test diagnostic pour mieux traiter le cancer    |     Friday 14 October 2016 - Future Medicine:   Specific immunotherapy in ovarian cancer: a systematic review    |     Friday 14 October 2016 - Future Medicine:   Review on the immunotherapy strategies against metastatic colorectal carcinoma    |     Thursday 13 October 2016 - Santé - Le Figaro:   L'immunothérapie bouleverse la prise en charge du cancer avancé du poumon    |    

Latest News

& Events